chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day1 - I started having a light headache and my right arm was little sore around 3pm on the day I got the shot. I was mostly doing fine that day. Day 2 - I woke up to nausea and feeling chilly around 4am the next morning. I got fever, headache and my whole body was sore. The body soreness was intense and it didn't make any difference if I lay on the bed or just sitting down. I didn't have any difficulty breathing but I was feeling tired the whole day. My temperature went down to 99.1F by evening but still had headache and soreness especially on my hips and legs so I took ibuprofen before going to bed. Day 3 - I woke up to feeling so much better. Just a little soreness on my right arm.
Muscle Aches, headache, low grade fever (responding to tylenol), slight itching and redness at injection site.
This is a spontaneous report from a contactable consumer (patient).   A 34-year-old male patient received BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: FC3181 and expiration date: not reported), via an unspecified route of administration, in Left Arm, on 19Aug2021 at 09:00 (at the age of 34-year-old) as DOSE 1, SINGLE for covid-19 immunization in Pharmacy or Drug Store.  No Medical history has been reported. No known allergies. The patient's concomitant medications were not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  The patient experienced tightness in upper left chest and Myocarditis dull pain on 20Aug2021. No treatment was received for the adverse events.  The outcome of the events was not recovered at time of report.  No follow-up attempts are needed. No further information is expected.
knee arthritis; cannot walk; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRITIS (non-serious), outcome "unknown", described as "knee arthritis"; GAIT INABILITY (non-serious), outcome "unknown", described as "cannot walk".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approximately 7 days after injection left arm with welt that spread out over arm warm, itchy and painful
Dizziness, hot feeling, sweaty, anxious, throat tingly, throat swelling, fast heartrate 5 minutes after vaccine. Rest of the day had a heavy chest, nausea, chills, tingly face, numb fingers and toes. Weeks later, late period.
On 10/22/2001 at 2:10pm guardian phoned office to report pt complained of headache on 10/21/2001. relieved with Tylenol. in am of 10/22/2001, complained of headache, sore throat and soreness in neck. Guardian was advised to take pt to ER and report back to this office. Did not report back.
Patient's injection site has has become infected and that she has cellulitis; Brachial neuritis; Injection site has has become infected; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE CELLULITIS (Patient's injection site has has become infected and that she has cellulitis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE CELLULITIS (Patient's injection site has has become infected and that she has cellulitis) (seriousness criterion medically significant) with VACCINATION SITE INFECTION (Injection site has has become infected) and RADICULITIS BRACHIAL (Brachial neuritis). At the time of the report, INJECTION SITE CELLULITIS (Patient's injection site has has become infected and that she has cellulitis) and RADICULITIS BRACHIAL (Brachial neuritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment for the events included steroids. When the steroids are stopped, the patient's condition flares up again. Patient has been referred to a Neurologist for treatment.   This case was linked to US-MODERNATX, INC.-MOD-2021-051579 (Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-051579: Crosslinked
Inflammation and hardness to filler areas; Inflammation and hardness to filler areas; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE INFLAMMATION (Inflammation and hardness to filler areas) and VACCINATION SITE INDURATION (Inflammation and hardness to filler areas) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: VARICELLA ZOSTER VACCINE (Patient had Restylane-L injected to upper cheeks on 18-Jun-2020.) on 17-Aug-2020.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (Inflammation and hardness to filler areas) and VACCINATION SITE INDURATION (Inflammation and hardness to filler areas). At the time of the report, VACCINATION SITE INFLAMMATION (Inflammation and hardness to filler areas) and VACCINATION SITE INDURATION (Inflammation and hardness to filler areas) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional Info Non Significant Followup
Fever, Chills, Body Aches, face numbness left side for 20 min, left arm wet sensation off and on 3-4 times through out next day
EXPIRED VACCINE DOSE GIVEN - PATIENT REPORTING NO SIDE EFFECTS OR ADVERSE EVENTS
Patient admitted for left ureteral stone and hydronephrosis. Cystoscopy with left ureteral stent placement. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
This case was reported by a pharmacist via call center representative and described the occurrence of vesicular rash in a 74-year-old female patient who received SHINGRIX (batch number 37KL2, expiry date 12th February 2021) for prophylaxis. Previously administered products included SHINGRIX (1st dose received on 16th April 2018 (batch number 539A2, expiry date 30th March 2020)). On 19th September 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced vesicular rash and nerve pain. On an unknown date, the outcome of the vesicular rash and nerve pain were not recovered/not resolved. It was unknown if the reporter considered the vesicular rash and nerve pain to be related to SHINGRIX. Additional details were provided as follows: The patient reported to the pharmacist, on the date of reporting that she had a shingles like rash and nerve pain on her lower back.
I woke up with bad tinnitus in my right ear that persisted for about 3 or 4 hours before going away. I also had a slight headache about 30 minutes after the injection that persisted for the rest of the afternoon and evening before going away with a single dose of ibuprofen before bed.
Patient received her covid vaccination at 1950, right deltoid.  She was escorted to the 30 minute waiting zone as she has had anaphylactic reactions in the past.  At 2008 patient stated she felt hot. She had a rash developing on her neck, noted a dry mouth and thickening tongue. EMS brought in for evaluation. Blood pressure 204/102, pulse 65, oxygen 100% on 2L nasal cannula. 50 mg benadryl administered IM left deltoid 2011. 20g PIV started left antecubital, 125 mg administered. Ambulance on site. Patient able to speak clearly, verbalized the need to void her bladder.  Patient accompanied by 2 RNs to the restroom. She was stable on her feet, escorted back to EMS stretcher. She was taken to hospital. VAERS submitted.
pt presented with SOB and hypoxia despite being on 3L O2 via NC; placed on nonrebreather; oxygen requirement increased; hypotension occurred; O2 sats dropped; pt was a DNR/DNI; condition declined and she died in the hospital
After giving injection and importing information into database we discovered pt. had previously received the Janssen vaccine on 3/10/21. I called pt. to ask if this information was correct and he said that "I didn't know that I could not receive both.". Pt, was asymptomatic at the time I spoke with him on the phone.
day of vaccine lost appetite by dinnertime day after vaccination-temperature 100 degrees, dizzy, weak, felt like I had the flu. Slept most of the day. next day lethargic, no energy, some headache next day dizzy and nauseous
RD-RCV'd 2 vaccines - RXN to vaccine area. Saw Dr & started on Keflex BIDx7days Follow up as needed.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 3/31/2021 and 4/27/2021. Presented to ED on 9/10/2021 with complaint of confusion, as per family this happens when patient has urinary tract infection. Patient stated that she took a home urinary tract infection test kit which resulted positive. She was evaluated for urinary tract infection, but urinalysis was unremarkable.  Chest x-ray was normal, but she underwent CT of the abdomen and pelvis which did show findings in the lung bases consistent with pneumonia versus pneumonitis.  She was prescribed doxycycline, but stopped taking it after 2 days due to nausea. Subsequently changed to levofloxacin on 9/14/2021 during follow-up clinic visit. On 9/16/2021 patient presented to ED with shortness of breath, labored breathing, fever and chills. Placed on 6L O2 NC. Despite aggressive treatment, she has deteriorated and is no longer alert but is obtunded. Family has decided to transition to comfort care. Patient expired 9/25/2021.
5 hours after injection, complained of stinging at site.  Ice applied.  1 hour later, 25 cent size reddened area on left deltoid.  WTT.  Ice applied again.
sick to the stomach; fever; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to the stomach), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease. Concomitant products included LEVOTHYROXINE, MULTIVITAMINS [VITAMINS NOS], ZINC and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. On 24-Mar-2021, ABDOMINAL DISCOMFORT (sick to the stomach), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-317960, MOD-2021-317961 (Patient Link).
Sharp, tingling pain in rt arm; shooting up through shoulder, neck, jaw, back of neck, and down arm to finger. Numbness in hand and finger. Lightheadeness and a little disoriented.
Patient was given a Moderna Booster on 8/10/22- Patient was 12y 5m. Provider noticed on 12/30/22 when she completed it.
TWINRIX (Rt arm) 8 pm 8/26. 3:30am 8/27 burning pain on rt. side of  body from neck shoulder to rt foot - searing on rt breast, chest, shoulder & arm; trouble breathing; pale, tired; nauseous - same event each early morning somewhat less severe thru 8/31/11. ER visit at 5:45 AM on 8/28. Tingling; numb tight chest, rapid heart beat, burning entire rt side of body - released 10AM.
This spontaneous report as received from a medical assistant refers to a 17-year-old patient of an unknown gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 30-APR-2018, the patient was inadvertently vaccinated with a dose of Oka-Merck PROQUAD injection, lot # N029672, expiration date 21-APR-2019, for prophylaxis (exact dose and route of administration were not provided). The vaccine was reconstituted with MERCK STERILE DILUENT. No adverse effects reported.
ACUTE NON ST ELEVATION MI ACUTE CORONARY SYNDROME, UNSPECIFIED 3/12/2023  &   3/1/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
She started getting a runny nose that caused her to cough while she was sleeping. On Monday the fifth her Dad took her to the doctor as she was still not feeling well. We had given her a home COVID-19 test that came back negative. They did not run any test and sent her home. Later that day she did start running a fever, we gave her some ibuprofen/TYLENOL to bring the fever down. She woke up on Tuesday with no fever, by that evening she was more like herself. By Wednesday she was feeling much better and went back to daycare.
Raised, hot, red rash at right knee, bilateral elbows, and midback.  Itchiness was 8/10 itchy per patient.
General malaise; swollen lymph node under left armpit; Joint pain in legs; other vaccine same date: Flu shot; other vaccine same date: Flu shot; Dose number 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), intramuscular, administered in arm left, administration date 11Nov2021 14:30 (Lot number: FG3527) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administered in arm left, administration date 11Nov2021 (Batch/Lot number: unknown) as dose 1, single. The patient had no relevant medical history. Concomitant medication(s) included: TESTOSTERONE. Vaccination history included: Comirnaty (Dose Number: 2, Batch/Lot No: EL3247, Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM, Route of Administration: Intramuscular), administration date: 16Feb2021, when the patient was 33 years old, for COVID-19 immunization; Comirnaty (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM, Route of Administration: Intramuscular), administration date: 27Jan2021, when the patient was 33 years old, for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 11Nov2021, outcome "unknown" and all described as "other vaccine same date: Flu shot"; IMMUNISATION (non-serious) with onset 11Nov2021, outcome "unknown", described as "Dose number 3"; MALAISE (non-serious) with onset 12Nov2021 07:00, outcome "recovered" (Nov2021), described as "General malaise"; LYMPHADENOPATHY (non-serious) with onset 12Nov2021 07:00, outcome "recovered" (Nov2021), described as "swollen lymph node under left armpit"; ARTHRALGIA (non-serious) with onset 12Nov2021 07:00, outcome "recovered" (Nov2021), described as "Joint pain in legs". Therapeutic measures were not taken as a result of malaise, lymphadenopathy, arthralgia.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient had no known allergies.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 30-JUN-2015, the patient was vaccinated with an improperly stored dose of VAQTA 10 Pk 25U/0.5 ml SD Llok w Cap Ped, which had the lot # L001445, with expiration date 15-FEB-2016 (dose, dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On an unspecified date the vaccine experienced a temperature excursions of 24 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree). The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator (R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Low-grade fever (never above 99.5), chills, diarrhea, dizziness, fatigue, nausea; all started approximately 17 hours after injection; chills dissipated first (around 20 hours later); dizziness, nausea, and diarrhea off and on all day, fatigue all day.  All symptoms dissipated after approximately 30-31 hours after the injection.
caught long COVID; caught long COVID; had not taste; had not smell; it was really bizarre; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "caught long COVID"; AGEUSIA (medically significant), outcome "unknown", described as "had not taste"; ANOSMIA (medically significant), outcome "unknown", described as "had not smell"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "it was really bizarre".  Clinical course: Caller mentioned: "I had both shots of the vaccine and one booster, then I was in the hospital, caught long COVID, had not taste or smell for like a year, it was really bizarre, then I felt better, I went to get the Pfizer booster, because I was in the Doctor's office yesterday." Caller stated that his doctor is not open today and the only choice would be to go to the Hospital, but he really does not want to go the Hospital and then described his symptoms as being "not constant or consistent, long stop, kind of comes and goes and then is not, is irritating, is not life threating." Caller also asked: Can I start with a cool compress, that is not going to hurt me, or I can consider calling.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Linked Report(s) : US-PFIZER INC-202300063621 Same reporter/patient, same drug/different dose, different AEs;
Pain (L) shoulder radiating to forearm. Joint pain. Rash along forearm.
pt recv vax 20JUN96 in lt deltoid;pain that day;1JUL96 devel pain burning sensation lt arm;some numbness, weakness;strength on testing w/definite weakness lt grip, biceps, radidis 5JUL96;resolved 19JUL96;EMG 12JUL OK;
Patient given bivalent 12 and up which is 0.3 ml when patient was supposed to receive pfizer bivalent 5-11 0.2 mL.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and unkonwn gender. Pertinent medical history, drug reactions or allergies were unspecified. On an unspecified dates, since 10-JUN-2014, an unspecified number of patients were vaccinated with M-M-R II (that were exposed to a supported temperature excursion on 10-JUN-2014). No adverse experience had been reported. No concomitant therapies were reported. The outcome of the event was unknown. Additional information has been requested.
Progressively worsening chest pain for several weeks after receiving the Smallpox vaccine. Admitted to hospital. Discharge diagnosis was myocarditis.
Very sore are for 2 days. Extreme tiredness for 1 week I'm now at the 2 week mark and just developed swelling, redness, hardness & warmth at the injection site.
Very sore arm after second shot immediately (not the case in first shot).  Chills started about 8 hours after second dose.   Very bad headaches and body aches began approx 12-14 hours after receiving shot.   Tiredness.  Lack of appetite.  This lasted approximately 16 hours.  2 days after second shot headaches still remain (milder), energy still down, body aches have gone away.  Large rash has started on the arm I received the shot along with still being very sore at the injection site.
Received shot around 3:20 PM. Dizziness was first symptom followed by shaking, tightness of chest, shortness of breath, swelling of lips, numbness in face. Symptoms appeared around 3:40-3:45 PM.
Patient stated he had a bad reaction to the shingrix and did not want to get the second shot in the series. He stated that his throat was swollen and closed on the right side. All reactions were on the right side. He also said he had an ear ache, headache and sore neck.
Injections were extremely painful.  Second injection caused flu like symptons associated with fever.  Site at injections were extremely painful, sore and red for several days.  Guardisil was the injections given.
sore arm; slight sore throat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and OROPHARYNGEAL PAIN (slight sore throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and OROPHARYNGEAL PAIN (slight sore throat). At the time of the report, PAIN IN EXTREMITY (sore arm) and OROPHARYNGEAL PAIN (slight sore throat) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Patient has taken no medications for his side effects and letting it run its course.
On 4/11/2021 I noticed I had a big rash. it was swollen, hot to the touch, & itchy.  Had a telehealth appointment he said just to look out for sever side effects but that this was common and not to worry.
Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Shakiness-Severe, Additional Details: jerking movements for a couple of seconds loss of consciousness lots of sweating, never confirmed by ems but for a moment felt like seizure for very short time i would same about 30 sec-40 sec